# Placebo-controlled Study to Evaluate Rexlemestrocel-L Alone or Combined With Hyaluronic Acid in Participants With Chronic Low Back Pain

> **NCT02412735** · PHASE3 · COMPLETED · sponsor: **Mesoblast, Ltd.** · enrollment: 404 (actual)

## Conditions studied

- Degenerative Disc Disease

## Interventions

- **DRUG:** Rexlemestrocel-L
- **DRUG:** Rexlemestrocel-L + HA Mixture
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02412735
- **Lead sponsor:** Mesoblast, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-06
- **Primary completion:** 2020-05-15
- **Final completion:** 2021-06-15
- **Target enrollment:** 404 (ACTUAL)
- **Last updated:** 2022-10-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02412735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02412735, "Placebo-controlled Study to Evaluate Rexlemestrocel-L Alone or Combined With Hyaluronic Acid in Participants With Chronic Low Back Pain". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02412735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*